普罗帕酮与胺碘酮在心律失常中治疗效果差异及对血清高敏C反应蛋白水平影响观察

Effect Difference of Propafenone and Amiodarone in the Treatment of Arrhythmia and Their Effects on Serum High Sensitivity C Reactive Protein Level

目的:分析针对心律失常患者采取普罗帕酮、胺碘酮在临床治疗上的功能与价值差异。方法:选取2018年3月~2019年5月期间收治心律失常患者共计200例,划分对照组和观察组各100例,对照组采取普罗帕酮治疗,观察组采取胺碘酮治疗,对比两组患者血清高敏C反应蛋白水平、治疗效果以及并发症的情况。结果:通过研究结果得知,观察组患者在临床治疗有效性方面达到90%,对比对照组55%差异显著;在血清高敏C反应蛋白与并发症的抑制方面,观察组同样优于对照组。结论:针对心律失常患者采取胺碘酮治疗,相比于普罗帕酮更能够适应临床需求,提升治疗效果的同时抑制并发症的发病率,建议推广使用。

Objective:To analyze the difference in the function and value of propafenone and amiodarone in the clinical treatment of arrhythmia patients.Methods:A total of 200 patients with arrhythmia from March 2018 to May 2019 were selected and divided into the control group and the observation group,with 100 cases in each group.The control group was treated with propafenone and the observation group was treated with amiodarone,then the serum high-sensitivity C reactive protein levels,therapeutic effects and complications were compared between the two groups.Results:The results showed that the effectiveness of clinical treatment in the observation group reached 90%,which was significantly different from the control group(55%).As for the inhibition of serum hypersensitive C reactive protein and complications,the observation group was also superior to the control group.Conclusion:Compared with propafenone,amiodarone can better adapt to clinical needs,improve the therapeutic effect and inhibit the incidence of complications,which is worthy of promotion and application.